Access to anti-retroviral drugs, male in Croatia

Croatia: Access to anti-retroviral drugs, male was 84.0% in 2024. ▲ Rising

Latest (2024)
84.0%
Change on year
up 1.2%
World rank
36th
of 141 countries
All-time high
84.0%
in 2024
All-time low
26.0%
in 2000
Years of data
25
2000–2024

Access to anti-retroviral drugs, male in Croatia, 2000–2024

204060802000201220242000: 26 %2001: 27 %2002: 29 %2003: 29 %2004: 30 %2005: 30 %2006: 31 %2007: 34 %2008: 37 %2009: 39 %2010: 42 %2011: 45 %2012: 48 %2013: 52 %2014: 56 %2015: 63 %2016: 69 %2017: 73 %2018: 75 %2019: 78 %2020: 78 %2021: 79 %2022: 82 %2023: 83 %2024: 84 %

Source: UNAIDS estimates. Measured in %.

Analysis

In 2024, access to anti-retroviral drugs, male in Croatia stood at 84.0%. That is the highest value across all 25 years on record.

The figure is up 1.2% on the previous year and up 50.0% over ten years.

Over the whole period, access to anti-retroviral drugs, male in Croatia peaked at 84.0% in 2024 and was at its lowest, 26.0%, in 2000.

Croatia ranks 36th of 141 countries on this measure, in the top quarter.

The long-run direction has been consistently rising across the 25 years of available data.

Access to anti-retroviral drugs, male in Croatia, year by year

Annual values for Access to anti-retroviral drugs, male (%) in Croatia, 2000 to 2024.
Year % Change
2000 26.0%
2001 27.0% +3.8%
2002 29.0% +7.4%
2003 29.0% +0.0%
2004 30.0% +3.4%
2005 30.0% +0.0%
2006 31.0% +3.3%
2007 34.0% +9.7%
2008 37.0% +8.8%
2009 39.0% +5.4%
2010 42.0% +7.7%
2011 45.0% +7.1%
2012 48.0% +6.7%
2013 52.0% +8.3%
2014 56.0% +7.7%
2015 63.0% +12.5%
2016 69.0% +9.5%
2017 73.0% +5.8%
2018 75.0% +2.7%
2019 78.0% +4.0%
2020 78.0% +0.0%
2021 79.0% +1.3%
2022 82.0% +3.8%
2023 83.0% +1.2%
2024 84.0% +1.2%

Averages by decade

DecadeAverage LowestHighest Years
2000s 31.2% 26.0% 39.0% 10
2010s 60.1% 42.0% 78.0% 10
2020s 81.2% 78.0% 84.0% 5

Countries ranked near Croatia

  1. 34 Italy 85.0% compare
  2. 34 New Zealand 85.0% compare
  3. 36 Eswatini 84.0% compare
  4. 36 Kenya 84.0% compare
  5. 36 Nigeria 84.0% compare

See the full ranking of 160 places →

More gender data for Croatia

All data for Croatia →

Frequently asked questions

What is access to anti-retroviral drugs, male in Croatia?
Access to anti-retroviral drugs, male in Croatia was 84.0% in 2024, according to UNAIDS estimates.
What is the highest access to anti-retroviral drugs, male recorded in Croatia?
The highest recorded value was 84.0% in 2024.
What is the lowest access to anti-retroviral drugs, male recorded in Croatia?
The lowest recorded value was 26.0% in 2000.
How does Croatia rank for access to anti-retroviral drugs, male?
Croatia ranks 36th out of 141 countries with data for 2024.
Is access to anti-retroviral drugs, male rising or falling in Croatia?
Over the last ten years it is up 50.0%. The long-run trend across the full record is rising.
Where does this Croatia data come from?
The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Access to anti-retroviral drugs, male in Croatia. Statizoid, drawing on UNAIDS estimates. Retrieved 11 September 2026, from https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-male-percent/croatia/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-male-percent/croatia/">Access to anti-retroviral drugs, male in Croatia</a> — Statizoid

About this data

Indicator
Access to anti-retroviral drugs, male (%)
Unit
%
Source
UNAIDS estimates
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
160 places, 3,923 data points, 2000–2024
Last refreshed

The percentage of adult males living with HIV who are receiving antiretroviral therapy.